Siswanto serves as fresh instruction on the vigorous scrutiny that courts apply.
Identifying the purpose of the deposition and working backward can help guide you through it.
The Eleventh Circuit once again confirms that it is difficult to achieve class certification for these cases because of the individualized nature of the injuries.
Federal preemption of state law is one of the most significant defenses employed by drug and medical device manufacturers defending product liability lawsuits.
By Paul D. Rheingold
Some new provisions will aid tort plaintiffs, and other changes that may appear to be impediments to full discovery are likely not to be applied in the manner hoped for by early drafters.
By Matthew A. Moeller
In toxic-tort matters, experts may be held to a standard more rigorous than what may be allowable under the general Daubert framework in another type of case.
Max Herman reviews the state of cybersecurity at mass tort firms and offers suggestions to help project such information in the future. (11:16 min)
Max Herman explains the benefits of MFNs and how settlement curves are effected by them. (13:54 min)
Matthew Moeller outlines ways to manage E-Discovery that will streamline your case and keep your clients happy. (06:26 min)
Examining the holding in this newly announced decision and what it may mean for future parens patriae actions and other types of quasi-class actions or mass actions. (56:12)
Featuring a unique group of lawyers and non-lawyers to provide a fact-based peek into the future, including presentations and an interactive discussion among the panelists. (1:01:42)
Learn about the significance of the Barltett decision and its impact on the Supreme Court's preemption holdings. (57:33)
The latest edition of Mass Torts is now available.
Mass Torts Leadership
|Cochairs||Web Editor||Newsletter Editor|
Kansas City, MO
Leadership Development & Young Lawyer Outreach Liaison
Sun Valley, CA